We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

118 hedge funds and large institutions have $264M invested in Albany Molecular Research Inc in 2013 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

82% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 28

15% more funds holding

Funds holding: 103 → 118 (+15)

13% more call options, than puts

Call options by funds: $1.43M | Put options by funds: $1.26M

2% less capital invested

Capital invested by funds: $269M → $264M (-$4.3M)

Holders
118
Holders Change
+15
Holders Change %
+14.56%
% of All Funds
3.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
51
Reduced
28
Closed
9
Calls
$1.43M
Puts
$1.26M
Net Calls
+$169K
Net Calls Change
+$101K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$28.4M
2
VAM
Visium Asset Management
New York
+$13.5M
3
BIT
BlackRock Institutional Trust
California
+$6.67M
4
RA
Royce & Associates
New York
+$5.05M
5
JP Morgan Chase
JP Morgan Chase
New York
+$3.81M

Top Sellers

Rank Fund Capital Flow
1
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$4.57M
2
TC
TFS Capital
Pennsylvania
-$3.62M
3
BIM
Bogle Investment Management
Massachusetts
-$3.6M
4
EI
EAM Investors
California
-$2.48M
5
Invesco
Invesco
Georgia
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
RFC
26
Russell Frank Company
Washington
$2.11M -$1.72M -142,275 -42%
GC
27
Guggenheim Capital
Illinois
$1.95M +$2.34M +193,659 New
AI
28
Analytic Investors
California
$1.86M +$1.1M +90,960 +98%
Goldman Sachs
29
Goldman Sachs
New York
$1.82M +$539K +44,579 +33%
CBOA
30
Commonwealth Bank of Australia
Australia
$1.82M +$931K +77,060 +75%
SFM
31
Systematic Financial Management
New Jersey
$1.73M +$673K +55,725 +48%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.65M +$614K +50,788 +49%
PPA
33
Parametric Portfolio Associates
Washington
$1.5M +$503K +41,585 +39%
PCM
34
Piermont Capital Management
Missouri
$1.47M +$1.77M +146,260 New
AG
35
Algert Global
California
$1.21M +$211K +17,500 +17%
GCP
36
GSA Capital Partners
United Kingdom
$1.2M +$91.2K +7,545 +7%
LSV Asset Management
37
LSV Asset Management
Illinois
$1.17M +$1.41M +116,427 New
WIC
38
Woodmont Investment Counsel
Tennessee
$1.11M +$70.1K +5,800 +6%
TCIM
39
TIAA CREF Investment Management
New York
$1.04M – – –
Bessemer Group
40
Bessemer Group
New Jersey
$918K – – –
Deutsche Bank
41
Deutsche Bank
Germany
$904K +$736K +60,916 +211%
BIM
42
BlackRock Investment Management
Delaware
$798K -$25.7K -2,123 -3%
SO
43
STRS Ohio
Ohio
$717K +$61.6K +5,100 +8%
Axa
44
Axa
France
$674K +$44.7K +3,700 +6%
AQR Capital Management
45
AQR Capital Management
Connecticut
$654K +$4.36K +361 +0.6%
PAM
46
Panagora Asset Management
Massachusetts
$629K -$3.69K -305 -0.5%
BMCMI
47
Bryn Mawr Capital Management Inc
Pennsylvania
$606K +$727K +60,147 New
Asset Management One
48
Asset Management One
Japan
$594K +$115K +9,512 +19%
CAM
49
ClariVest Asset Management
California
$580K -$17.1K -1,419 -2%
HK
50
Horizon Kinetics
New York
$564K – – –
1
2
3 4 5

AMRI Hedge Fund Activity: Q4 2013 in Review

118 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2013, worth a combined $264M — down 1.6% from $269M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AMRI positions and 9 closed out — a net gain of 15 holders — while 51 added to existing stakes and 28 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $28.4M. The largest seller was Fuller & Thaler Asset Management, exiting entirely with an estimated $4.57M sold.

  • 118 institutional investors held Albany Molecular Research Inc (AMRI) as of Q4 2013, up from 103 in Q3 2013.
  • Funds reported $264M of Albany Molecular Research Inc stock for Q4 2013, down 1.6% quarter-over-quarter.
  • 24 funds opened new Albany Molecular Research Inc positions in Q4 2013 and 9 closed out, a net change of +15 holders.
  • The largest Albany Molecular Research Inc buyer in Q4 2013 was Wellington Management Group, an estimated $28.4M added.
  • The largest Albany Molecular Research Inc seller in Q4 2013 was Fuller & Thaler Asset Management, an estimated $4.57M sold.

Based on aggregated 13F filings for Q4 2013.